You are here
FDA Approves Allergic Rhinitis Medication for Use in Pregnant Women
The approval was based on evidence that the medication did not cause an increased risk of birth defects. All other medications in the class approved by the FDA for the treatment of allergic rhinitis are rated Pregnancy Category C. The achievement of a Category B rating indicates that adequate studies in pregnant women have demonstrated that there is no evidence of risk to the fetus during the first trimester of pregnancy and in later trimesters. This may give physicians greater confidence in prescribing a particular medication for women of child-bearing age or during pregnancy.
Pregnant women are often warned to limit medications. For those that suffer from nasal allergies, this can lead to an uncomfortable nine months. During pregnancy allergy symptoms may become worse and combined with what's called stuffy nose of pregnancy women can be miserable.
For more information about nasal allergies and Rhinocort Aqua, please visit www.categoryb.com, or call 800-236-9933.